TY - JOUR
T1 - Cardiovascular Risk Factors and Atherosclerotic Cardiovascular Events Among Incident Cases of Systemic Sclerosis
T2 - Results From a Population-Based Cohort (1980-2016)
AU - Kurmann, Reto D.
AU - Sandhu, Avneek S.
AU - Crowson, Cynthia S.
AU - Matteson, Eric L.
AU - Osborn, Thomas G.
AU - Warrington, Kenneth J.
AU - Mankad, Rekha
AU - Makol, Ashima
N1 - Funding Information:
Grant Support: This study was made possible using the resources of the Rochester Epidemiology Project, which is supported by the National Institute on Aging of the National Institutes of Health (NIH) under award number R01AG034676 (Principal Investigators: Walter A. Rocca, MD, MPH and Jennifer L. St Sauver, PhD), and grant number UL1 TR000135 from the National Center for Advancing Translational Sciences , a component of the NIH. The study was also supported by the John M. Nasseff, Sr. Clinician Career Development Award in Rheumatology (A.M.) and Mayo Clinic Clinical and Translational Science Award through grant number UL1 TR002377 from the National Center for Advancing Translational Sciences , a component of the NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Publisher Copyright:
© 2019 Mayo Foundation for Medical Education and Research
PY - 2020/7
Y1 - 2020/7
N2 - Objective: To characterize cardiovascular (CV) risk factors and outcomes among incident cases of systemic sclerosis (SSc) in a population-based cohort. Methods: Medical records of patients with SSc diagnosed in Olmsted County, Minnesota, between January 1, 1980, and December 31, 2016, were reviewed to identify 78 incident SSc cases. The comparators were 156 sex- and age-matched individuals from the same population. Data for SSc characteristics, traditional CV risk factors, and CV events were collected. Cumulative incidence was adjusted for the competing risk for death. Results: During a median follow-up of 9.8 (SSc) and 9.2 years (non-SSc), 21 patients with SSc and 17 patients without SSc developed CV events, corresponding to 10-year cumulative incidence of 24.4% and 15.2%, respectively. The risk for incident CV disease was increased by 2-fold (hazard ratio, 2.38; 95% CI, 1.28-4.43) in patients with SSc vs comparators, predominately due to coronary artery disease (hazard ratio, 2.35; 95% CI, 1.17-4.71). Mean body mass index and prevalence of diabetes mellitus were lower in SSc vs non-SSc. There was no significant difference in smoking, hypertension, or hyperlipidemia. Observed CV events were increased compared with CV events predicted by the Framingham Risk Score and American College of Cardiology/American Heart Association score with standardized incident ratios of 4.16 (95% CI, 2.16-7.99) and 5.69 (95% CI, 2.71-11.94), respectively. Conclusion: Patients with SSc are at >2-fold increased risk for experiencing a CV event compared with persons without SSc. Framingham Risk Score and American College of Cardiology/American Heart Association score dramatically underestimate CV risk in SSc.
AB - Objective: To characterize cardiovascular (CV) risk factors and outcomes among incident cases of systemic sclerosis (SSc) in a population-based cohort. Methods: Medical records of patients with SSc diagnosed in Olmsted County, Minnesota, between January 1, 1980, and December 31, 2016, were reviewed to identify 78 incident SSc cases. The comparators were 156 sex- and age-matched individuals from the same population. Data for SSc characteristics, traditional CV risk factors, and CV events were collected. Cumulative incidence was adjusted for the competing risk for death. Results: During a median follow-up of 9.8 (SSc) and 9.2 years (non-SSc), 21 patients with SSc and 17 patients without SSc developed CV events, corresponding to 10-year cumulative incidence of 24.4% and 15.2%, respectively. The risk for incident CV disease was increased by 2-fold (hazard ratio, 2.38; 95% CI, 1.28-4.43) in patients with SSc vs comparators, predominately due to coronary artery disease (hazard ratio, 2.35; 95% CI, 1.17-4.71). Mean body mass index and prevalence of diabetes mellitus were lower in SSc vs non-SSc. There was no significant difference in smoking, hypertension, or hyperlipidemia. Observed CV events were increased compared with CV events predicted by the Framingham Risk Score and American College of Cardiology/American Heart Association score with standardized incident ratios of 4.16 (95% CI, 2.16-7.99) and 5.69 (95% CI, 2.71-11.94), respectively. Conclusion: Patients with SSc are at >2-fold increased risk for experiencing a CV event compared with persons without SSc. Framingham Risk Score and American College of Cardiology/American Heart Association score dramatically underestimate CV risk in SSc.
UR - http://www.scopus.com/inward/record.url?scp=85086923817&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85086923817&partnerID=8YFLogxK
U2 - 10.1016/j.mayocp.2019.12.015
DO - 10.1016/j.mayocp.2019.12.015
M3 - Article
C2 - 32622445
AN - SCOPUS:85086923817
SN - 0025-6196
VL - 95
SP - 1369
EP - 1378
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 7
ER -